Today's career fair will focus on the following graduate programs offered by Temple University's School of Pharmacy:

The PhD (Doctor of Philosophy) and MS (Master of Science) degrees in Pharmaceutical Sciences with concentrations in Medicinal Chemistry, Pharmaceutics or Pharmacodynamics.  (For these thesis-based programs, chat with Dr. Daniel Canney)

There is also a non-thesis MS in Pharmaceutics.  Some required courses for this program are taught in a traditional classroom setting in Fort Washington, PA.  Two required courses and many electives are entirely online.  

The MS in Regulatory Affairs and Quality Assurance (RAQA) - the nation's first academic degree in this field celebrating its 50th anniversary in 2018.  Temple's MS in RAQA is widely recognized as the most comprehensive and largest program of its kind with more than 2100 graduates working in the FDA or regulated industry (including pharmaceutical, medical device, biotechnology,  generics and biosimilars, and related disciplines).

The MS in Global Clinical and Pharmacovigilance Regulations (GCPR), which prepares PharmD and MD graduates for careers in benefit-risk analysis for healthcare products.

For questions about the MS in RAQA or the MS in GCPR, please make sure you chat with RAQA staff, including Patricia Lee, Sylvia McNally, Jean Westbrook, or Brenda Haslego.  

Temple University School of Pharmacy is located on the Health Sciences Campus of Temple University, providing outstanding opportunities for cross-disciplinary learning with other healthcare programs, including Temple's Medical, Dental, and Podiatric Schools plus the College of Public Health.

Our RAQA and GCPR graduate programs are based at Fort Washington, PA, in the heart of the East Coast pharmaceutical industry.  The School has a strong relationship with FDA and the nation's top pharmaceutical companies.  It is possible to complete both degrees entirely online, in live, interactive courses, where you'll study with students across the U.S. and the world.

To learn more about our programs: 

RAQA:  www.temple.edu/pharmacy_QARA        Email:  QARA@temple.edu

GCPR: www.temple.edu/pharmacy_qara/MS_Global_Clinical_Pharmacovigilance_Regulations.html    Email:  QARA@temple.edu

Non-Thesis MS in Pharmaceutics: www.temple.edu/pharmacy_qara/pharmaceutics.htm   Email: canney@temple.edu

Admissions:  https://pharmacy.temple.edu/admissions  OR http://www.temple.edu/pharmacy_qara/applying_to_RAQA_programs.htm

We welcome your participation and look forward to chatting with you today!

Key Faculty

Dr. Daniel Canney, Associate Professor and Director of Graduate Studies

Research and Labs

• The Current Good Manufacturing Practices Lab
• The Jayne Haines Center for Pharmacogenomics and Drug Safety
• The Moulder Center for Drug Discovery Research

Tuition and other Financial Information:

Graduate Programs
PA Residents = $3,216 for each 3-credit course

Non-PA Residents = $4,074 for each 3-credit course

www.temple.edu/bursar/about/tuitionrates.htm

Recognition and Awards

Accreditation Statement
Accreditation Council for Pharmacy Education certifies that Temple University School of Pharmacy has fulfilled the accreditation requirements set forth by ACPE for the Professional Degree Program in Pharmacy and is hereby granted: Accreditation Status through
June 30, 2025.

AWARDS

• Dr. Abou-Gharbia (P.I.) and several TUSP colleagues (Drs. Childers, Blass and Korzekwa) received an NIH RO1 award of $1.9 million to study GLT-1 enhancers as candidates for cocaine addiction; this award was in partnership with colleagues at Johns Hopkins University and the University of Florida.
•  Dr. Wayne Childers (Co-I) received $450,000 as part of a $2.5 million NIH study awarded to Dr. Tomasz Skorski of TUMS to study DNA repair in refractory/resistant myelogenous leukemia, and $730,000 from the Department of Defense to study inhibitors of botulinum protease.
• Dr. Ben Blass received an NIH award of $648,000 to develop D3 receptor compounds for the treatment of psychostimulant abuse, with collaborators from North Texas Health Sciences Center, University of Pennsylvania and Arizona State University. He also received support from the Biostrategy Partnership ($60,000) for the development of 5HT7 antagonists to treat inflammatory bowel syndrome, and from the University City Sciences Center QED Proof of Concept program ($200,000) to explore the use of GLT-1 expression modulators in the treatment of ALS.
• Dr. Jason Gallagher has been named a Fellow of the Infectious Diseases Society of America (IDSA) in recognition of having “achieved Professional excellence in infectious diseases”. 
• Dr. Salim Merali  received  an NIH RO3 Award entitled: “Activators of Nrf2 Translation in Alzheimer’s Disease “ in the amount of $156,000 for a period of two years. Dr. Carlos Barrero is also a Co-Investigator on this grant.

University/School History

Temple University School of Pharmacy (TUSP) was established in 1901 to provide students access to professional education in the discipline of pharmacy. Reasons for considering TUSP as an institution of your choice includes:
LOCATION — 6th largest comprehensive Health Sciences campus in America & epicenter of the pharmaceutical industry.
DIVERSITY — enrollment of a diverse student population from all parts of America and the world.

OPPORTUNITIES FOR PROFESSIONAL LEARNING
Among the top 100 USA research intensive institutions
The Moulder Center for Drug Discovery Research
The Jayne Haines Center for Pharmaco-Genomics and Drug Safety
Has one of only 6 cGMP manufacturing facilities in the country.
Nuclear Magnetic Resonance (NMR) Facility